Quantitative Investment Management, LLC Exelixis, Inc. Transaction History

Quantitative Investment Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$18.39 - $24.8 $2.16 Million - $2.91 Million	-117,275 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$20.67 - $26.94 $99,836 - $130,120	4,830 Added 4.3%	117,275 $2.87 Million
Q2 2020 Aug 14, 2020	BUY	$16.46 - $27.42 $1.85 Million - $3.08 Million	112,445 New	112,445 $2.67 Million
Q1 2019 May 15, 2019	SELL	$19.6 - $24.76 $535,080 - $675,948	-27,300 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$13.65 - $21.8 $202,020 - $322,640	14,800 Added 118.4%	27,300 $536,000
Q3 2018 Nov 14, 2018	BUY	$15.87 - $22.4 $198,375 - $280,000	12,500 New	12,500 $221,000
Q1 2018 May 15, 2018	SELL	$22.15 - $31.89 $1.17 Million - $1.69 Million	-53,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$24.23 - $30.93 $1.28 Million - $1.64 Million	53,000	53,000 $1.61 Million

501

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Investment Management, LLC with notifications on news.